Curaleaf International launches CPD-accredited medical cannabis education platform
Curaleaf International has launched a CPD-accredited medical cannabis education platform to support clinicians. This platform provides structured learning pathways to improve cannabis clinical knowledge. It addresses the critical need for accredited…
85% of U.S. Healthcare Professionals Believe Cannabis Has Medical Utility
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicyPainAnxietyMental HealthSafetyDosing Why This Matters Healthcare professionals' widespread…
DEA’s Own Pharmacologist Undercuts Marijuana Rescheduling Order
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchNeurologyMental HealthSafetyIndustryPain Why This Matters A DEA pharmacologist's testimony suggesting…
Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDTHCResearchSafetyIndustry Why This Matters Wyoming's rejection of federal Schedule III…
No longer able to purchase out-of-state, Ky medical cannabis patients suffer sticker shock
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PainPolicyIndustrySafetyAnxietyMental HealthDosing Why This Matters Kentucky's elimination of out-of-state cannabis…
Developments in Cannabis Withdrawal and Addiction Treatment
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthSafetyTHCAnxietyDosingPolicy Why This Matters Clinicians need updated evidence on cannabis…
Cheap, High-THC Products Are Driving Germany’s Medical Cannabis Market
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchTHCIndustryPainMental HealthSafety Why This Matters Clinicians in Germany and similar regulated markets…
Dateline Rice for July 8, 2026
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. THCPolicySafetyMental HealthResearchNeurologyPain Dr. Caplan's Take I appreciate the article's framing, but I…
VFF Stock Decline: Evaluating Cannabis Industry Financial Performance
This article analyzes cannabis industry financial performance, focusing on VFF stock's 27% loss over three months. It highlights the impact of stock fluctuations on patient access and industry consolidation. Clinicians should prioritize clinical evidence…
Structural and biochemical basis for cannabinoid cyclase activity in marine bacterial flavoenzymes
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchCBDTHCSafetyPolicyPainAnxiety Clinical Summary This biochemistry research elucidates the structural mechanisms…